The complexities of territorial licensing
Companies in the biotech and pharmaceutical industry are well known for developing and implementing innovative deal structures in order to realise the maximum value from their assets and to get products to market. One of those innovative deal structures is geographical licensing. While apparently simple on the face of it, the devil is in the detail.
Geographical licensing is the practice where the owner of the rights to a product grants to a licensee the exclusive right to develop and/or commercialise the product in a specific country or territory only. The licensor may grant a separate licence to several different licensees, each in a distinct country or territory. The licensor may, or may not, reserve for itself the right to develop and commercialise the product in a particular country or territory.
The complexities of this deal structure arise from the fact that there needs to be a degree of either centralised control or decentralised co-ordination in relation to a number of matters — particularly regulatory compliance and intellectual property management. Such centralised control or decentralised co-ordination needs to be acceptable to all parties involved, not all of whom may be known or identified at the time of entering into the first licence. Clearly, the complexities increase as the number of licensees increases. The deal may be further complicated if, prior to commercialisation, the licensor works with one or more of the licensees to undertake development work to get the product to market…
Click on the link below to read the rest of the Taylor Wessing briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world